Abstract: An ameliorating agent for cancer chemotherapy is disclosed, which comprises a chromanol glycoside represented by the following general formula (1) (wherein R1, R2, R3, and R4, which are identical or different from each other, stand for a hydrogen atom or a lower alkyl group, R5 stands for a hydrogen atom, a lower alkyl group, or a lower acyl group, X stands for a monosaccharide residue or an oligosaccharide residue optionally having the hydrogen atom of the hydroxyl group in the saccharide residue substituted with a lower alkyl group or a lower acyl group, n is an integer in the range of 0-6, and m is an integer in the range of 1-6). According to this invention, a novel ameliorating agent for cancer chemotherapy is provided which acts safely and effectively in a small dosage to enhance the carcinostatic action of an anti-cancer agent in cancer chemotherapy and repressing side effects by cancer chemotherapy as well.

Abstract: An ameliorating agent for cancer chemotherapy is disclosed, which comprises a chromanol glucoside represented by the following general formula (1) (wherein R1, R2, R3, and R4, which are identical or different from each other, stand for a hydrogen atom or a lower alkyl group, R5 stands for a hydrogen atom, a lower alkyl group, or a lower acyl group, X stands for a monosaccharide residue or an oligosaccharide residue optionally having the hydrogen atom of the hydroxyl group in the saccharide residue substituted with a lower alkyl group or a lower acyl group, n is an integer in the range of 0-6, and m is an integer in the range of 1-6). According to this invention, a novel ameliorating agent for cancer chemotherapy is provided which acts safely and effectively in a small dosage to enhance the carcinostatic action of an anti-cancer agent in cancer chemotherapy and repressing side effects by cancer chemotherapy as well.

Abstract: A 2-nitroimidazole compound of the formula: ##STR1## wherein R.sub.f is a fluorine-containing organic group which has at least one fluorine atom on a carbon atom which bonds to the nitrogen atom of the imidazole ring or a carbon atom which bonds to said carbon atom and a radiosensitizer comprising said nitroimidazole derivative.

Abstract: A 2-nitroimidazole derivative of the formula: ##STR1## wherein R.sub.f is a group of the following formula (II) or (III):--CH.sub.2 CFXCH.sub.2 OR.sub.1 (II)wherein X is a hydrogen atom or a halogen atom; R.sub.1 is a group of the formula: ##STR2## wherein R.sub.2 is a hydrogen atom, a hydroxyl group, a C.sub.1 -C.sub.3 alkyl group, a C.sub.2 -C.sub.4 acyl group, benzylidene or acetonide; R.sub.3 is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group; Z is a hydrogen atom, COOY, COOR.sub.3, CONHOY, CONR.sub.4 R.sub.5 (wherein R.sub.4 and R.sub.5 are hydroxyl group-containing C.sub.1 -C.sub.3 alkyl groups or hydrogen atoms; Y is a hydrogen atom or a monovalent metal atom), an amino group, a hydroxyl group or OR.sub.3 ; l is an integer of 1 to 3; o is an integer of 0 to 3; p is an integer of 0 to 2; q is an integer of 0 to 3; m and n are integers of 0 to 4; and 1.ltoreq.m+n.ltoreq.4 or ##STR3## wherein R.sub.3, X and p are the same as defined above; Z' is the same as Z or is OCOOCH.sub.

Abstract: A nitroazole derivative of the formula:NA--R.sub.f (I)wherein NA is 3-nitro-1,2,4-triazol-l-yl and R.sub.f is a fluorine-containing organic group which is useful as a radiosensitizer.

Abstract: A radiation sensitizer of the present invention contains a particular nitrotriazole compound as an active ingredient and accelerates inactivation of intractable hypoxic cells in a malignant tumor by irradiation.

Abstract: Electric wire coated by a non-flammable resin, characterized in that the resin is composed of two layers, the degrees of crosslinking of which are different from each other, and the gel percent of the outer portion of the resin is lower than that of the inner portion of the resin is disclosed.

Abstract: The oxidation of a high polymer such as polyvinyl chloride or polyolefin, which oxidation causes cleavages of carbon-carbon bonds in the main chains thereof to degrade the high polymer into lower molecular weight compounds, is remarkably accelerated when the high polymer is impregnated with a halogenated compound having a carbonyl group or carbonyl groups and exposed to sunlight or is irradiated with ultraviolet radiation in an ambient atmosphere of oxygen or a gas containing oxygen. This acceleration of the oxidation makes possible easy destruction of a shaped article made of such a high polymer.